1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Drug Self-Administration to 2022

Drug Self-Administration to 2022

  • December 2014
  • -
  • Greystone Research Associates

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors are converging to create both risk and opportunity for drug makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, caregiver safety legislation, and continued pressure to control healthcare costs.

These factors are giving rise to a new generation of sophisticated, application-specific injection, inhalation and transdermal drug products designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the formulation limitations of new classes of therapeutic drugs. Because of their ability to safely and reliably satisfy treatment protocols and compliance goals, non-oral drug delivery products will have a significant impact on the future of drug self-administration.

Highlights
- Provides detailed analysis of drug self-administration market segments, market dynamics and market demographics

- Analyzes therapeutic demand drivers and evaluates commercial drug products in more than two dozen major self-administration therapeutic segments

- Analyzes design factors, material selection issues, technologies and market development issues for injection devices, inhalation devices and transdermal drug products designed for self-administration

- Charts product data, market share, and forecasts to 2022

- Profiles self-administration drug product and device participants, their product development activities, business strategies, and corporate alliances and affiliations

Table Of Contents

Drug Self-Administration to 2022
Summary of Contents
Executive Summary

Drug Market Dynamics

Evolving Drug Development and Market Factors
Managed Care and Prescribing Trends
Drug Self-Administration Demand Factors
Shifting Patient Demographics
Chronic Disease and Self-administration
Biological Drugs Proliferating
Delivery Device Technology and Evolving

Drug Self-Administration Product Segments and Market Drivers

Injectable Drug Self-Administration
Market Sector Dynamics
Prefilled Syringes (PFS)
Glass PFS
Plastic PFS
Autoinjectors
Pen Injectors
Reusable Pens
Disposable Pens
Needle-free Injectors (NFI)
Competitive NFI Therapeutic Segments
Needle-free Company Profiles

Inhaled Drug Self-Administration Products
Market Sector Dynamics
The Upper Respiratory Market
The Systemic/Deep Lung Market
Inhaler Technology and Market Prospects
Inhaler Product Segments
Dry Powder Inhalers
Metered Dose Inhalers
Nebulizers
Performance Factors
Bioavailability
Dose Reproducibility
Active Compound Stability

Transdermal Drug Products
Market Sector Dynamics
Prescription Patch Design and Technology
Active Transport Patch Technologies
Prescription Patch Development Factors
Key Transdermal Therapeutic Markets
Transdermal Product Company Profiles

Drug Self-Administration - Therapeutic Sector Analysis and Forecasts
ADHD
Anticoagulants
Arthritis
Asthma/COPD
Cardiovascular
Contraception
Cystic Fibrosis
Diabetes
Hematopoietics
Hepatitis
Hormone Therapy/Replacement
Multiple Sclerosis
Neurology
Osteoporosis
Pain Management
Psoriasis
Sexual Health

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
European Market Report for Peripheral Intravenous Catheters 2017 - MedCore

European Market Report for Peripheral Intravenous Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European PIVC market includes three segments: conventional PIVCs, safety PIVCs and midlines. The safety PIVC segment includes three sub-segments: active safety PIVCs, passive safety PIVCs ...

Facial Injectables Market - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Facial Injectables Market - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

North America Facial Injectables Market: Overview This report on the North America facial injectables market analyzes the current and future prospects of the market. The report comprises an elaborate executive ...

Medical Foam Market by Material Type, Form, Application, and Region - Global Forecast to 2026

Medical Foam Market by Material Type, Form, Application, and Region - Global Forecast to 2026

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

“The global medical foam market size is projected to reach USD 30.89 billion by 2026” The global medical foam market is projected to grow from USD 14.06 billion in 2016 to USD 30.89 billion by 2026, ...


Download Unlimited Documents from Trusted Public Sources

Topical Delivery Industry in the US

  • January 2017
    9 pages
  • Topical Deliver...  

    DNA  

  • United States  

View report >

Pulmonary Delivery Industry

  • November 2016
    2 pages
  • Pulmonary Deliv...  

    Respiratory Tre...  

    Food  

View report >

Drug Delivery Industry

  • November 2016
    9 pages
  • Anti-Infective  

View report >

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.